Meta-Analysis
Copyright ©The Author(s) 2022.
World J Clin Cases. Dec 16, 2022; 10(35): 12959-12970
Published online Dec 16, 2022. doi: 10.12998/wjcc.v10.i35.12959
Figure 3
Figure 3 Network forest plots. A: Network forest plot [odds ratio (OR); 95% credible interval [CrI]) of all patients (intention-to-treat) showing the regimens compared directly with the proton pump inhibitor-triple therapy regimen as the reference; B: Network forest plot (OR; 95% CrI) of clarithromycin-resistant strains showing that the efficacy of the regimens compared with PPI-triple therapy was consistent with that in network forest plot A; C: Network forest plot of clarithromycin-susceptible strains describing the efficacy of the regimens compared directly with the PPI-triple therapy regimen as the reference; D: Network forest plot of metronidazole-resistant strains showing the efficacy of the regimens compared directly with the PPI-triple therapy reference regimen. CrI: Credible interval; ITT: Intention-to-treat; Vono: Vonoprazan; PPI: Proton pump inhibitor; HD: High-dose; QT: Quadruple therapy.